In a population-based analysis of 371,032 UK Biobank participants, faster biological aging in males explained a substantial proportion of their higher cardiovascular disease (CVD) risk compared with females, accounting for about 60–68% of the excess risk across major CVD outcomes. Although males and females had similar chronological ages, males consistently showed higher risks of any CVD, atrial fibrillation, coronary heart disease, heart failure, and stroke, while females experienced CVD onset 0.7 to 2.9 years later. Males also exhibited a faster biological aging pace of 1.02 years, measured by phenotypic age acceleration and telomere length, with unhealthy lifestyles contributing the largest share, followed by chronic diseases and metabolic factors. Differences in biological aging pace explained most of the male-associated excess risk across CVD subtypes, and results were consistent when alternative aging measures were used or when accounting for sex hormones, underscoring biological aging pace as a key contributor to sex disparities in CVD and a potential target for sex-specific primary prevention. Source: https://academic.oup.com/eurjpc/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.